Form 4 for BIIB Biogen
Accepted 2022-01-21 00:00:00 ET · period of report 2022-01-19 · accession 0001127602-22-001863 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-21 | 2022-01-19 | BIIB | Gregory Ginger | EVP, Human Resources | A - Grant | $0.00 | +1,941 | 10.0K | +24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-19 | A | A | 1,941 | $0.00 | 10,027.62 | D | — | — | (F1) Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2019. The shares will vest on February 12, 2022. (F2) Includes 71.5888 shares, 14,2341 shares, 10.4331 shares and .0001 share acquired under the Biogen Inc. employee stock purchase plan on 3/31/2021, 6/30/2021, 9/30/2021 and 12/31/2021, respectively. |